NCT05268003: A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia, Leukemia